C-X-C chemokine receptor 4 (CXCR4) expression on tumor cells has been associated with an unfavorable progression and metastasis in cancers including melanoma, ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer [17]. This evidence concerns the gene CXCR4 and familial pancreatic carcinoma.